PGI13 A COST UTILITY ANALYSIS OF PEGUINTERFERON ALFA 2B (I2KD) (PEG2B)VERSUS PEGUINTERFERON ALFA 2A (40KD) (PEG2A) FOR THE TREATMENT OF CHRONIC HEPATITIS C (CHC) IN BRAZIL
Abstract
Authors
M Fonseca G Araujo
M Fonseca G Araujo
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now